| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane-ephrin receptor activity | 2.71e-16 | 15 | 149 | 9 | GO:0005005 | |
| GeneOntologyMolecularFunction | ephrin receptor activity | 4.87e-15 | 19 | 149 | 9 | GO:0005003 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | EPHB2 EPHB3 EPHA6 RET EFNA4 MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.74e-12 | 65 | 149 | 11 | GO:0004714 |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | EPHB2 EPHB3 EPHA6 RET EFNA4 MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.66e-11 | 85 | 149 | 11 | GO:0019199 |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | EPHB2 EPHB3 ABL1 EPHA6 RET EFNA4 SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 6.51e-11 | 145 | 149 | 13 | GO:0004713 |
| GeneOntologyMolecularFunction | GPI-linked ephrin receptor activity | 4.49e-10 | 7 | 149 | 5 | GO:0005004 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | EPHB2 TRPM6 EPHB3 ERVK-6 ABL1 EPHA6 GALT RET EFNA4 PDIK1L DGUOK SYK PIPSL PTGES3 MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.25e-05 | 938 | 149 | 20 | GO:0016772 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.92e-05 | 26 | 149 | 4 | GO:0005248 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB2 TRPM6 EPHB3 ABL1 EPHA6 RET EFNA4 PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 4.41e-05 | 600 | 149 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | kinase activity | EPHB2 TRPM6 EPHB3 ABL1 EPHA6 RET EFNA4 PDIK1L DGUOK SYK PIPSL MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 5.77e-05 | 764 | 149 | 17 | GO:0016301 |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | EPHB2 EPHB3 TSPAN12 OR8J2 ABCA1 EPHA6 GPR183 RET NMUR2 DCC GLP2R SORT1 NPY4R2 ADRA2A EFNA4 NPY4R IL21R SCN7A MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 6.39e-05 | 1353 | 149 | 24 | GO:0004888 |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB2 TRPM6 EPHB3 ABL1 EPHA6 RET EFNA4 PDIK1L SYK PIPSL MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 8.19e-05 | 709 | 149 | 16 | GO:0016773 |
| GeneOntologyMolecularFunction | ephrin receptor binding | 9.10e-05 | 32 | 149 | 4 | GO:0046875 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 1.10e-04 | 13 | 149 | 3 | GO:0008046 | |
| GeneOntologyMolecularFunction | peptidase activity | TRHDE CPA6 ERVK-6 RNPEPL1 MMP27 ERVK-21 MEP1B FAP RNPEP PRCP C1S ERVK-19 ERVK-25 MMP8 USP33 | 1.16e-04 | 654 | 149 | 15 | GO:0008233 |
| GeneOntologyMolecularFunction | peptide binding | EPHB2 TRHDE TRAV12-2 NMUR2 GSS SLC7A9 NPY4R2 RNPEP NPY4R EPHA4 | 1.41e-04 | 318 | 149 | 10 | GO:0042277 |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.62e-04 | 37 | 149 | 4 | GO:0004190 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.77e-04 | 110 | 149 | 6 | GO:0008238 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.80e-04 | 38 | 149 | 4 | GO:0070001 | |
| GeneOntologyMolecularFunction | pancreatic polypeptide receptor activity | 3.29e-04 | 4 | 149 | 2 | GO:0001602 | |
| GeneOntologyMolecularFunction | sodium channel activity | 6.10e-04 | 52 | 149 | 4 | GO:0005272 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 CACNA1F CACNA2D1 HCN3 NMUR2 CLIC5 SCN4A SCN7A SCN9A TRPM1 VDAC1 | 6.75e-04 | 459 | 149 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | structural constituent of eye lens | 7.35e-04 | 24 | 149 | 3 | GO:0005212 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 7.71e-04 | 200 | 149 | 7 | GO:0008237 | |
| GeneOntologyMolecularFunction | metalloaminopeptidase activity | 9.33e-04 | 26 | 149 | 3 | GO:0070006 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 1.16e-03 | 28 | 149 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 MMP27 ERVK-21 MEP1B FAP C1S ERVK-19 ERVK-25 MMP8 USP33 | 1.48e-03 | 430 | 149 | 10 | GO:0004175 |
| GeneOntologyMolecularFunction | metalloexopeptidase activity | 1.86e-03 | 70 | 149 | 4 | GO:0008235 | |
| GeneOntologyMolecularFunction | sterol binding | 1.96e-03 | 71 | 149 | 4 | GO:0032934 | |
| GeneOntologyMolecularFunction | channel activity | TRPM6 CACNA1F CACNA2D1 HCN3 NMUR2 CLIC5 SCN4A SCN7A SCN9A TRPM1 VDAC1 | 1.98e-03 | 525 | 149 | 11 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | TRPM6 CACNA1F CACNA2D1 HCN3 NMUR2 CLIC5 SCN4A SCN7A SCN9A TRPM1 VDAC1 | 2.01e-03 | 526 | 149 | 11 | GO:0022803 |
| GeneOntologyMolecularFunction | neuropeptide binding | 2.63e-03 | 37 | 149 | 3 | GO:0042923 | |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 2.91e-03 | 11 | 149 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | neuropeptide Y receptor activity | 2.91e-03 | 11 | 149 | 2 | GO:0004983 | |
| GeneOntologyBiologicalProcess | ephrin receptor signaling pathway | 1.69e-10 | 54 | 149 | 9 | GO:0048013 | |
| GeneOntologyBiologicalProcess | axon guidance | EPHB2 EPHB3 EPHA6 LAMA5 RET DCC EFNA4 TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.06e-08 | 285 | 149 | 14 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | EPHB2 EPHB3 EPHA6 LAMA5 RET DCC EFNA4 TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.16e-08 | 286 | 149 | 14 | GO:0097485 |
| GeneOntologyBiologicalProcess | axonogenesis | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.49e-07 | 566 | 149 | 18 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 9.35e-07 | 642 | 149 | 18 | GO:0061564 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 ATXN2 VPS13A TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.37e-06 | 802 | 149 | 20 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 ATXN2 VPS13A TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.89e-06 | 819 | 149 | 20 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | EPHB2 EPHB3 ABL1 EPHA6 PSG9 RET SORT1 ADRA2A EFNA4 VPS13A SYK MUSK VAV2 FOXC1 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.94e-06 | 747 | 149 | 19 | GO:0007169 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 CLIC5 TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.98e-06 | 748 | 149 | 19 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 ATXN2 VPS13A TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.16e-06 | 826 | 149 | 20 | GO:0048858 |
| GeneOntologyBiologicalProcess | synapse organization | EPHB2 EPHB3 ABL1 FRMPD4 CNTNAP1 SLITRK4 LAMA5 ACTN1 SORT1 PTPN13 ARHGEF9 TNR MUSK EPHA3 EPHA4 EPHA5 EPHA7 | 9.65e-06 | 685 | 149 | 17 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 ACTN1 RET DCC CRYGB EFNA4 CLIC5 ATXN2 VPS13A TNR USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.57e-05 | 1194 | 149 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection development | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 CLIC5 ATXN2 WASHC5 DGUOK VPS13A TNR MUSK USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.67e-05 | 1285 | 149 | 24 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EPHB2 EPHB3 CACNA1F ABL1 EPHA6 CNTNAP1 SLITRK4 LAMA5 RET DCC EFNA4 OLFM3 CLIC5 ATXN2 WASHC5 DGUOK VPS13A TRPM1 TNR MUSK USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.68e-05 | 1463 | 149 | 26 | GO:0048666 |
| GeneOntologyBiologicalProcess | postsynapse organization | EPHB2 EPHB3 FRMPD4 CNTNAP1 LAMA5 ACTN1 ARHGEF9 MUSK EPHA4 EPHA5 EPHA7 | 1.77e-05 | 313 | 149 | 11 | GO:0099173 |
| GeneOntologyBiologicalProcess | visual perception | 4.60e-05 | 230 | 149 | 9 | GO:0007601 | |
| GeneOntologyBiologicalProcess | neuron projection fasciculation | 4.68e-05 | 28 | 149 | 4 | GO:0106030 | |
| GeneOntologyBiologicalProcess | axonal fasciculation | 4.68e-05 | 28 | 149 | 4 | GO:0007413 | |
| GeneOntologyBiologicalProcess | sensory perception of light stimulus | 5.09e-05 | 233 | 149 | 9 | GO:0050953 | |
| GeneOntologyBiologicalProcess | fasciculation of motor neuron axon | 5.18e-05 | 2 | 149 | 2 | GO:0097156 | |
| GeneOntologyBiologicalProcess | central nervous system projection neuron axonogenesis | 8.04e-05 | 32 | 149 | 4 | GO:0021952 | |
| GeneOntologyBiologicalProcess | fasciculation of sensory neuron axon | 1.55e-04 | 3 | 149 | 2 | GO:0097155 | |
| GeneOntologyBiologicalProcess | cellular response to follicle-stimulating hormone stimulus | 1.58e-04 | 15 | 149 | 3 | GO:0071372 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 1.98e-04 | 74 | 149 | 5 | GO:0050885 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.32e-04 | 169 | 149 | 7 | GO:0010977 | |
| GeneOntologyBiologicalProcess | cell junction organization | EPHB2 EPHB3 ABL1 FRMPD4 PSG9 CNTNAP1 SLITRK4 LAMA5 ACTN1 SORT1 PTPN13 ARHGEF9 TNR MUSK EPHA3 EPHA4 EPHA5 EPHA7 | 2.39e-04 | 974 | 149 | 18 | GO:0034330 |
| GeneOntologyBiologicalProcess | central nervous system neuron axonogenesis | 2.59e-04 | 43 | 149 | 4 | GO:0021955 | |
| GeneOntologyBiologicalProcess | multicellular organismal response to stress | 3.10e-04 | 126 | 149 | 6 | GO:0033555 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | EPHB2 EPHB3 ABL1 EPHA6 PSG9 RET SORT1 UBE2O ADRA2A EFNA4 VPS13A SYK MUSK VAV2 FOXC1 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.51e-04 | 1186 | 149 | 20 | GO:0007167 |
| GeneOntologyBiologicalProcess | response to follicle-stimulating hormone | 4.47e-04 | 21 | 149 | 3 | GO:0032354 | |
| GeneOntologyBiologicalProcess | regulation of axonogenesis | 5.01e-04 | 192 | 149 | 7 | GO:0050770 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | 5.01e-04 | 385 | 149 | 10 | GO:0070372 | |
| GeneOntologyBiologicalProcess | cellular response to gonadotropin stimulus | 5.14e-04 | 22 | 149 | 3 | GO:0071371 | |
| GeneOntologyBiologicalProcess | regulation of synapse organization | EPHB2 EPHB3 ABL1 FRMPD4 CNTNAP1 SLITRK4 PTPN13 MUSK EPHA4 EPHA7 | 5.21e-04 | 387 | 149 | 10 | GO:0050807 |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 EPHB3 CACNA1F ABL1 FRMPD4 EPHA6 WFS1 HCN3 ACTN1 RET SORT1 SHISA9 ADRA2A WASHC5 VPS13A TRPM1 PTGES3 USP33 EPHA3 EPHA4 SHISA8 EPHA5 EPHA7 EPHA8 | 7.07e-06 | 1228 | 150 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | dendrite | EPHB2 EPHB3 ABL1 FRMPD4 EPHA6 WFS1 HCN3 ACTN1 RET SORT1 SHISA9 TRPM1 EPHA3 EPHA4 SHISA8 EPHA5 EPHA7 EPHA8 | 4.48e-05 | 858 | 150 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | EPHB2 EPHB3 ABL1 FRMPD4 EPHA6 WFS1 HCN3 ACTN1 RET SORT1 SHISA9 TRPM1 EPHA3 EPHA4 SHISA8 EPHA5 EPHA7 EPHA8 | 4.62e-05 | 860 | 150 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | extracellular matrix of synaptic cleft | 1.53e-04 | 3 | 150 | 2 | GO:0098965 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 2.29e-04 | 17 | 150 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | EPHB2 FRMPD4 DCC SORT1 SHISA9 ADRA2A ARHGEF9 TNR VDAC1 EPHA4 SHISA8 EPHA7 | 4.02e-04 | 523 | 150 | 12 | GO:0098984 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA1F CACNA2D1 HCN3 SHISA9 OLFM3 CLIC5 SCN4A SCN7A SCN9A SHISA8 | 4.13e-04 | 378 | 150 | 10 | GO:0034702 |
| GeneOntologyCellularComponent | postsynaptic membrane | EPHB2 CACNA2D1 DCC SHISA9 ADRA2A MUSK VDAC1 EPHA4 SHISA8 EPHA7 | 7.04e-04 | 405 | 150 | 10 | GO:0045211 |
| GeneOntologyCellularComponent | postsynaptic density membrane | 9.59e-04 | 157 | 150 | 6 | GO:0098839 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.15e-03 | 29 | 150 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | AMPA glutamate receptor complex | 1.28e-03 | 30 | 150 | 3 | GO:0032281 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.29e-03 | 112 | 150 | 5 | GO:0031594 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 2.09e-14 | 14 | 138 | 8 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 2.09e-14 | 14 | 138 | 8 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 2.09e-14 | 14 | 138 | 8 | IPR001426 | |
| Domain | EphA2_TM | 2.09e-14 | 14 | 138 | 8 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 2.09e-14 | 14 | 138 | 8 | IPR001090 | |
| Domain | Eph_TM | 2.09e-14 | 14 | 138 | 8 | IPR027936 | |
| Domain | EPH_lbd | 2.09e-14 | 14 | 138 | 8 | SM00615 | |
| Domain | Ephrin_lbd | 2.09e-14 | 14 | 138 | 8 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 2.09e-14 | 14 | 138 | 8 | IPR016257 | |
| Domain | EPH_LBD | 2.09e-14 | 14 | 138 | 8 | PS51550 | |
| Domain | Tyr_kinase_cat_dom | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.07e-12 | 88 | 138 | 12 | IPR020635 |
| Domain | TyrKc | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.07e-12 | 88 | 138 | 12 | SM00219 |
| Domain | Galactose-bd-like | EPHB2 EPHB3 EPHA6 CNTNAP1 LAMA5 F8 MEP1B EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 4.64e-12 | 94 | 138 | 12 | IPR008979 |
| Domain | PROTEIN_KINASE_TYR | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 6.80e-12 | 97 | 138 | 12 | PS00109 |
| Domain | Tyr_kinase_AS | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 6.80e-12 | 97 | 138 | 12 | IPR008266 |
| Domain | Ephrin_rec_like | 7.04e-12 | 25 | 138 | 8 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 7.04e-12 | 25 | 138 | 8 | IPR011641 | |
| Domain | - | 1.46e-10 | 73 | 138 | 10 | 2.60.120.260 | |
| Domain | Pkinase_Tyr | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.04e-10 | 129 | 138 | 12 | PF07714 |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 4.50e-10 | 138 | 138 | 12 | IPR001245 |
| Domain | - | 6.09e-09 | 106 | 138 | 10 | 1.10.150.50 | |
| Domain | SAM/pointed | 1.59e-08 | 117 | 138 | 10 | IPR013761 | |
| Domain | FN3 | EPHB2 EPHB3 EPHA6 DCC IL21R FNDC9 TNR EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.89e-08 | 199 | 138 | 12 | PS50853 |
| Domain | SAM_DOMAIN | 3.46e-08 | 95 | 138 | 9 | PS50105 | |
| Domain | SAM | 4.16e-08 | 97 | 138 | 9 | IPR001660 | |
| Domain | FN3_dom | EPHB2 EPHB3 EPHA6 DCC IL21R FNDC9 TNR EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 4.98e-08 | 209 | 138 | 12 | IPR003961 |
| Domain | FN3 | EPHB2 EPHB3 EPHA6 DCC IL21R TNR EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.29e-07 | 185 | 138 | 11 | SM00060 |
| Domain | SAM | 2.83e-07 | 88 | 138 | 8 | SM00454 | |
| Domain | fn3 | 3.48e-07 | 162 | 138 | 10 | PF00041 | |
| Domain | Ephrin_rec_like | 9.04e-07 | 11 | 138 | 4 | PF07699 | |
| Domain | Protein_kinase_ATP_BS | EPHB2 EPHB3 ABL1 EPHA6 RET PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 4.82e-06 | 379 | 138 | 13 | IPR017441 |
| Domain | SAM_1 | 1.10e-05 | 68 | 138 | 6 | PF00536 | |
| Domain | Kinase-like_dom | EPHB2 TRPM6 EPHB3 ABL1 EPHA6 RET PTPN13 PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.17e-05 | 542 | 138 | 15 | IPR011009 |
| Domain | Ion_trans_dom | 2.20e-05 | 114 | 138 | 7 | IPR005821 | |
| Domain | Ion_trans | 2.20e-05 | 114 | 138 | 7 | PF00520 | |
| Domain | EGF_2 | 2.81e-05 | 265 | 138 | 10 | PS01186 | |
| Domain | PROTEIN_KINASE_ATP | EPHB2 EPHB3 ABL1 EPHA6 RET PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.66e-05 | 459 | 138 | 13 | PS00107 |
| Domain | Na_channel_asu | 4.56e-05 | 10 | 138 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 4.56e-05 | 10 | 138 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 4.56e-05 | 10 | 138 | 3 | PF06512 | |
| Domain | NPY4_rcpt | 5.42e-05 | 2 | 138 | 2 | IPR001933 | |
| Domain | Prot_kinase_dom | EPHB2 EPHB3 ABL1 EPHA6 RET PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 6.97e-05 | 489 | 138 | 13 | IPR000719 |
| Domain | PROTEIN_KINASE_DOM | EPHB2 EPHB3 ABL1 EPHA6 RET PDIK1L SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 7.57e-05 | 493 | 138 | 13 | PS50011 |
| Domain | Peptidase_M1 | 8.27e-05 | 12 | 138 | 3 | IPR001930 | |
| Domain | ZINC_PROTEASE | 8.80e-05 | 98 | 138 | 6 | PS00142 | |
| Domain | Peptidase_M1_N | 1.07e-04 | 13 | 138 | 3 | IPR014782 | |
| Domain | Peptidase_M1 | 1.07e-04 | 13 | 138 | 3 | PF01433 | |
| Domain | Growth_fac_rcpt_ | 1.61e-04 | 156 | 138 | 7 | IPR009030 | |
| Domain | Beta/gamma_crystallin | 1.68e-04 | 15 | 138 | 3 | IPR001064 | |
| Domain | CRYSTALLIN_BETA_GAMMA | 1.68e-04 | 15 | 138 | 3 | PS50915 | |
| Domain | Crystall | 1.68e-04 | 15 | 138 | 3 | PF00030 | |
| Domain | XTALbg | 1.68e-04 | 15 | 138 | 3 | SM00247 | |
| Domain | SAM_2 | 2.82e-04 | 43 | 138 | 4 | PF07647 | |
| Domain | G_crystallin-rel | 2.97e-04 | 18 | 138 | 3 | IPR011024 | |
| Domain | TRPM_tetra | 3.22e-04 | 4 | 138 | 2 | PF16519 | |
| Domain | Peptidase_M1_C | 3.22e-04 | 4 | 138 | 2 | IPR015211 | |
| Domain | Leuk-A4-hydro_C | 3.22e-04 | 4 | 138 | 2 | SM01263 | |
| Domain | Leuk-A4-hydro_C | 3.22e-04 | 4 | 138 | 2 | PF09127 | |
| Domain | TRPM_tetra | 3.22e-04 | 4 | 138 | 2 | IPR032415 | |
| Domain | EGF-like_CS | 7.26e-04 | 261 | 138 | 8 | IPR013032 | |
| Domain | Ig-like_fold | EPHB2 EPHB3 EPHA6 PSG9 DCC IL21R FNDC9 TNR MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 7.46e-04 | 706 | 138 | 14 | IPR013783 |
| Domain | Lipase_euk | 7.97e-04 | 6 | 138 | 2 | IPR025483 | |
| Domain | Abhydro_lipase | 7.97e-04 | 6 | 138 | 2 | PF04083 | |
| Domain | AB_hydrolase_lipase | 7.97e-04 | 6 | 138 | 2 | IPR006693 | |
| Domain | Channel_four-helix_dom | 8.32e-04 | 57 | 138 | 4 | IPR027359 | |
| Domain | - | 8.32e-04 | 57 | 138 | 4 | 1.20.120.350 | |
| Domain | Fibrinogen_C | 1.01e-03 | 27 | 138 | 3 | PF00147 | |
| Domain | Glutathione_S-Trfase_N | 1.01e-03 | 27 | 138 | 3 | IPR004045 | |
| Domain | Peptidase_Metallo | 1.25e-03 | 29 | 138 | 3 | IPR006026 | |
| Domain | FBG | 1.25e-03 | 29 | 138 | 3 | SM00186 | |
| Domain | ZnMc | 1.25e-03 | 29 | 138 | 3 | SM00235 | |
| Domain | - | EPHB2 EPHB3 EPHA6 PSG9 DCC IL21R TNR MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.28e-03 | 663 | 138 | 13 | 2.60.40.10 |
| Domain | - | 1.38e-03 | 30 | 138 | 3 | 3.90.215.10 | |
| Domain | Fibrinogen_a/b/g_C_1 | 1.38e-03 | 30 | 138 | 3 | IPR014716 | |
| Domain | FIBRINOGEN_C_1 | 1.67e-03 | 32 | 138 | 3 | PS00514 | |
| Domain | Fibrinogen_a/b/g_C_dom | 1.67e-03 | 32 | 138 | 3 | IPR002181 | |
| Domain | FIBRINOGEN_C_2 | 1.67e-03 | 32 | 138 | 3 | PS51406 | |
| Domain | Shisa | 1.89e-03 | 9 | 138 | 2 | PF13908 | |
| Domain | Shisa | 1.89e-03 | 9 | 138 | 2 | IPR026910 | |
| Domain | NPY_rcpt | 1.89e-03 | 9 | 138 | 2 | IPR000611 | |
| Domain | GST_CTER | 2.00e-03 | 34 | 138 | 3 | PS50405 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 2.17e-03 | 35 | 138 | 3 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 2.76e-03 | 38 | 138 | 3 | PS00690 | |
| Domain | Glutathione-S-Trfase_C-like | 2.97e-03 | 39 | 138 | 3 | IPR010987 | |
| Domain | - | 2.97e-03 | 39 | 138 | 3 | 1.20.1050.10 | |
| Domain | ABC_A | 3.41e-03 | 12 | 138 | 2 | IPR026082 | |
| Domain | - | 4.65e-03 | 14 | 138 | 2 | 2.60.40.420 | |
| Domain | PreATP-grasp_dom | 4.65e-03 | 14 | 138 | 2 | IPR016185 | |
| Domain | Pept_M10A_Zn_BS | 5.34e-03 | 15 | 138 | 2 | IPR021158 | |
| Domain | Gal_mutarotase_SF_dom | 6.85e-03 | 17 | 138 | 2 | IPR011013 | |
| Domain | Hemopexin_CS | 6.85e-03 | 17 | 138 | 2 | IPR018486 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 4.48e-12 | 51 | 108 | 10 | M27311 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 1.40e-10 | 34 | 108 | 8 | MM15025 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.73e-09 | 29 | 108 | 7 | M27309 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 1.95e-09 | 92 | 108 | 10 | M27201 | |
| Pathway | KEGG_AXON_GUIDANCE | EPHB2 EPHB3 ABL1 EPHA6 DCC EFNA4 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.98e-09 | 129 | 108 | 11 | M5539 |
| Pathway | PID_EPHA_FWDPATHWAY | 5.77e-09 | 34 | 108 | 7 | M177 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 3.21e-08 | 65 | 108 | 8 | MM14911 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 1.90e-07 | 18 | 108 | 5 | MM15023 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 EPHB3 ABL1 EPHA6 CNTNAP1 RET DCC EFNA4 SCN4A SCN7A SCN9A VAV2 USP33 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.40e-07 | 575 | 108 | 18 | M29853 |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | EPHB2 EPHB3 ABL1 EPHA6 RET DCC EFNA4 VAV2 USP33 EPHA4 EPHA7 EPHA8 | 7.27e-07 | 261 | 108 | 12 | MM15676 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB2 EPHB3 ABL1 EPHA6 RET DCC PPL EFNA4 LIPM VAV2 USP33 EPHA4 EPHA7 EPHA8 | 2.85e-05 | 502 | 108 | 14 | MM14537 |
| Pathway | WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER | 3.19e-04 | 43 | 108 | 4 | M39788 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.31e-04 | 121 | 108 | 6 | M872 | |
| Pubmed | 1.37e-16 | 21 | 153 | 9 | 9267020 | ||
| Pubmed | 1.37e-16 | 21 | 153 | 9 | 11128993 | ||
| Pubmed | Eph receptors and ephrins demarcate cerebellar lobules before and during their formation. | 1.37e-16 | 21 | 153 | 9 | 10495276 | |
| Pubmed | Developmental expression of Eph and ephrin family genes in mammalian small intestine. | 1.37e-16 | 21 | 153 | 9 | 20112066 | |
| Pubmed | Eph receptors and ephrins: regulators of guidance and assembly. | 1.37e-16 | 21 | 153 | 9 | 10730216 | |
| Pubmed | Eph receptors and their ephrin ligands are expressed in developing mouse pancreas. | 6.01e-16 | 24 | 153 | 9 | 16446123 | |
| Pubmed | EPHB2 EPHB3 ABL1 EPHA6 RET SYK MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 2.51e-15 | 83 | 153 | 12 | 11114734 | |
| Pubmed | Disruption of segmental neural crest migration and ephrin expression in delta-1 null mice. | 2.74e-15 | 17 | 153 | 8 | 12217323 | |
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 8.46e-15 | 19 | 153 | 8 | 12684176 | |
| Pubmed | 9.03e-15 | 11 | 153 | 7 | 10559410 | ||
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 1.40e-14 | 20 | 153 | 8 | 11256076 | |
| Pubmed | 1.40e-14 | 20 | 153 | 8 | 10207129 | ||
| Pubmed | 1.40e-14 | 20 | 153 | 8 | 9530499 | ||
| Pubmed | 1.40e-14 | 20 | 153 | 8 | 9576626 | ||
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 4.66e-14 | 13 | 153 | 7 | 17039519 | |
| Pubmed | 4.66e-14 | 13 | 153 | 7 | 12528186 | ||
| Pubmed | Promotion of proliferation in the developing cerebral cortex by EphA4 forward signaling. | 5.41e-14 | 23 | 153 | 8 | 19542359 | |
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 1.92e-13 | 42 | 153 | 9 | 11439183 | |
| Pubmed | 5.46e-13 | 9 | 153 | 6 | 11403717 | ||
| Pubmed | 1.36e-12 | 10 | 153 | 6 | 25073978 | ||
| Pubmed | 1.36e-12 | 10 | 153 | 6 | 28197551 | ||
| Pubmed | EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes. | 1.36e-12 | 10 | 153 | 6 | 16547242 | |
| Pubmed | 2.98e-12 | 11 | 153 | 6 | 15517401 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 5.94e-12 | 12 | 153 | 6 | 21465626 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 5.94e-12 | 12 | 153 | 6 | 19247962 | |
| Pubmed | Thalamic afferents influence cortical progenitors via ephrin A5-EphA4 interactions. | 6.42e-12 | 23 | 153 | 7 | 25480914 | |
| Pubmed | Area specificity and topography of thalamocortical projections are controlled by ephrin/Eph genes. | 9.22e-12 | 6 | 153 | 5 | 12895420 | |
| Pubmed | 9.22e-12 | 6 | 153 | 5 | 15996548 | ||
| Pubmed | 1.92e-11 | 14 | 153 | 6 | 26941654 | ||
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 1.92e-11 | 14 | 153 | 6 | 11222144 | |
| Pubmed | 5.07e-11 | 16 | 153 | 6 | 8755474 | ||
| Pubmed | 6.33e-11 | 51 | 153 | 8 | 19769959 | ||
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 8.55e-11 | 8 | 153 | 5 | 12124402 | |
| Pubmed | Topographic guidance labels in a sensory projection to the forebrain. | 1.92e-10 | 9 | 153 | 5 | 9883724 | |
| Pubmed | cDNA cloning and tissue distribution of five human EPH-like receptor protein-tyrosine kinases. | 3.60e-10 | 4 | 153 | 4 | 7898931 | |
| Pubmed | Quantitative assessment of computational models for retinotopic map formation. | 3.82e-10 | 10 | 153 | 5 | 25367067 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 3.82e-10 | 10 | 153 | 5 | 17304517 | |
| Pubmed | 6.98e-10 | 11 | 153 | 5 | 22171039 | ||
| Pubmed | 2.68e-09 | 117 | 153 | 9 | 17145500 | ||
| Pubmed | A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome. | EPHB2 TRHDE ABCA1 DHX38 RET EEF1G DUSP29 EIF3B MUSK MTMR9 EPHA3 EPHA4 EPHA5 EPHA7 | 5.91e-09 | 420 | 153 | 14 | 28065597 |
| Pubmed | Compensatory Actions of Ldb Adaptor Proteins During Corticospinal Motor Neuron Differentiation. | 6.59e-09 | 33 | 153 | 6 | 26830346 | |
| Pubmed | 2.23e-08 | 40 | 153 | 6 | 30898150 | ||
| Pubmed | 2.49e-08 | 8 | 153 | 4 | 10774725 | ||
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 10704386 | ||
| Pubmed | 4.46e-08 | 9 | 153 | 4 | 33253166 | ||
| Pubmed | Identification of tyrosine kinases expressed in the male mouse gubernaculum during development. | 7.64e-08 | 25 | 153 | 5 | 15254900 | |
| Pubmed | Genetic analysis of the role of Eph receptors in the development of the mammalian nervous system. | 8.35e-08 | 3 | 153 | 3 | 9321682 | |
| Pubmed | Identification of ocular regulatory functions of core histone variant H3.2. | 8.35e-08 | 3 | 153 | 3 | 36529279 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 27582484 | ||
| Pubmed | The gamma-crystallins and human cataracts: a puzzle made clearer. | 8.35e-08 | 3 | 153 | 3 | 10521291 | |
| Pubmed | 8.35e-08 | 3 | 153 | 3 | 12876325 | ||
| Pubmed | 1.16e-07 | 11 | 153 | 4 | 22065784 | ||
| Pubmed | 2.44e-07 | 59 | 153 | 6 | 31351040 | ||
| Pubmed | Eph receptor interclass cooperation is required for the regulation of cell proliferation. | 3.33e-07 | 4 | 153 | 3 | 27565439 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 12507494 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 10607706 | ||
| Pubmed | Graded and discontinuous EphA-ephrinB expression patterns in the developing auditory brainstem. | 3.33e-07 | 4 | 153 | 3 | 26906676 | |
| Pubmed | Differential regulation of gamma-crystallin genes during mouse lens development. | 3.33e-07 | 4 | 153 | 3 | 3792630 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 3428594 | ||
| Pubmed | Ephrins guide migrating cortical interneurons in the basal telencephalon. | 3.33e-07 | 4 | 153 | 3 | 20473036 | |
| Pubmed | Novel mutations in the gamma-crystallin genes cause autosomal dominant congenital cataracts. | 3.33e-07 | 4 | 153 | 3 | 12011157 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 15037589 | ||
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 3011643 | ||
| Pubmed | Temporal regulation of six crystallin transcripts during mouse lens development. | 3.33e-07 | 4 | 153 | 3 | 1623964 | |
| Pubmed | 3.33e-07 | 4 | 153 | 3 | 20621668 | ||
| Pubmed | Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. | 8.20e-07 | 17 | 153 | 4 | 12971893 | |
| Pubmed | Ryk-deficient mice exhibit craniofacial defects associated with perturbed Eph receptor crosstalk. | 8.29e-07 | 5 | 153 | 3 | 10932185 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 8.29e-07 | 5 | 153 | 3 | 12629516 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 9426193 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 19949912 | ||
| Pubmed | The ephrin signaling pathway regulates morphology and adhesion of mouse granulosa cells in vitro. | 8.29e-07 | 5 | 153 | 3 | 23242526 | |
| Pubmed | Vav family GEFs link activated Ephs to endocytosis and axon guidance. | 8.29e-07 | 5 | 153 | 3 | 15848800 | |
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 19289155 | ||
| Pubmed | 8.29e-07 | 5 | 153 | 3 | 10627816 | ||
| Pubmed | Eph receptors are involved in the activity-dependent synaptic wiring in the mouse cerebellar cortex. | 8.29e-07 | 5 | 153 | 3 | 21559471 | |
| Pubmed | Embryonic stem cells express multiple Eph-subfamily receptor tyrosine kinases. | 8.29e-07 | 5 | 153 | 3 | 8552593 | |
| Pubmed | Multiple signaling interactions of Abl and Arg kinases with the EphB2 receptor. | 8.29e-07 | 5 | 153 | 3 | 11494128 | |
| Pubmed | 1.33e-06 | 19 | 153 | 4 | 35294885 | ||
| Pubmed | Human gamma-crystallin genes. A gene family on its way to extinction. | 1.65e-06 | 6 | 153 | 3 | 2258929 | |
| Pubmed | Ephrin-B3 reverse signaling through Grb4 and cytoskeletal regulators mediates axon pruning. | 1.65e-06 | 6 | 153 | 3 | 19182796 | |
| Pubmed | Gamma-crystallins of the human eye lens: expression analysis of five members of the gene family. | 1.65e-06 | 6 | 153 | 3 | 3670288 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 9632142 | ||
| Pubmed | Ephrin-A binding and EphA receptor expression delineate the matrix compartment of the striatum. | 2.88e-06 | 7 | 153 | 3 | 10366629 | |
| Pubmed | 2.88e-06 | 7 | 153 | 3 | 7947319 | ||
| Pubmed | Zic2-dependent axon midline avoidance controls the formation of major ipsilateral tracts in the CNS. | 2.99e-06 | 23 | 153 | 4 | 24360543 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.22e-06 | 91 | 153 | 6 | 28558017 | |
| Pubmed | Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. | 4.60e-06 | 8 | 153 | 3 | 22568954 | |
| Pubmed | 4.60e-06 | 8 | 153 | 3 | 17884558 | ||
| Pubmed | Eph:ephrin-B1 forward signaling controls fasciculation of sensory and motor axons. | 4.60e-06 | 8 | 153 | 3 | 24056079 | |
| Pubmed | The homeodomain protein Vax2 patterns the dorsoventral and nasotemporal axes of the eye. | 6.88e-06 | 9 | 153 | 3 | 11830578 | |
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 10683176 | ||
| Pubmed | 6.88e-06 | 9 | 153 | 3 | 9707552 | ||
| Pubmed | Sox1 directly regulates the gamma-crystallin genes and is essential for lens development in mice. | 9.79e-06 | 10 | 153 | 3 | 9512512 | |
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 12970426 | ||
| Pubmed | Cryptic boundaries in roof plate and choroid plexus identified by intersectional gene activation. | 9.79e-06 | 10 | 153 | 3 | 12923530 | |
| Pubmed | EphB signaling regulates target innervation in the developing and deafferented auditory brainstem. | 9.79e-06 | 10 | 153 | 3 | 22021100 | |
| Pubmed | 9.79e-06 | 10 | 153 | 3 | 25923646 | ||
| Pubmed | EphB2 guides axons at the midline and is necessary for normal vestibular function. | 9.79e-06 | 10 | 153 | 3 | 10839360 | |
| Pubmed | Regulation of lens fiber cell differentiation by transcription factor c-Maf. | 9.79e-06 | 10 | 153 | 3 | 10383433 | |
| Pubmed | Yap and Taz are required for Ret-dependent urinary tract morphogenesis. | 1.03e-05 | 31 | 153 | 4 | 26243870 | |
| Interaction | EFNA5 interactions | 5.28e-07 | 68 | 143 | 7 | int:EFNA5 | |
| Interaction | SEC23B interactions | EPHB2 EPHA6 RET SYK KLHL12 MUSK SEC23B EPHA4 EPHA5 EPHA7 EPHA8 | 5.47e-07 | 222 | 143 | 11 | int:SEC23B |
| Interaction | EFNA1 interactions | 7.11e-07 | 103 | 143 | 8 | int:EFNA1 | |
| Interaction | EFNA4 interactions | EPHA6 WFS1 CNTRL EFNA4 WASHC5 XPO6 EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.13e-06 | 239 | 143 | 11 | int:EFNA4 |
| Interaction | EPHA3 interactions | 1.26e-06 | 111 | 143 | 8 | int:EPHA3 | |
| Interaction | EPHB2 interactions | 3.36e-06 | 216 | 143 | 10 | int:EPHB2 | |
| Interaction | EPHB4 interactions | 9.76e-06 | 146 | 143 | 8 | int:EPHB4 | |
| Interaction | STAM2 interactions | 1.03e-05 | 147 | 143 | 8 | int:STAM2 | |
| Interaction | SEC23A interactions | 1.44e-05 | 255 | 143 | 10 | int:SEC23A | |
| Interaction | FTSJ1 interactions | 1.55e-05 | 75 | 143 | 6 | int:FTSJ1 | |
| Interaction | ACBD3 interactions | 1.65e-05 | 259 | 143 | 10 | int:ACBD3 | |
| Interaction | UNC5B interactions | 2.96e-05 | 84 | 143 | 6 | int:UNC5B | |
| Interaction | EPHA7 interactions | 3.42e-05 | 282 | 143 | 10 | int:EPHA7 | |
| Interaction | CALM3 interactions | EPHB2 EPHA6 WFS1 SPECC1 VPS13A MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 3.46e-05 | 343 | 143 | 11 | int:CALM3 |
| Interaction | PIK3R2 interactions | 3.98e-05 | 230 | 143 | 9 | int:PIK3R2 | |
| Interaction | SEC24B interactions | 5.54e-05 | 240 | 143 | 9 | int:SEC24B | |
| Interaction | HSPA1B interactions | EPHB2 EPHA6 CNTRL CNTNAP1 MUSK EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 5.91e-05 | 301 | 143 | 10 | int:HSPA1B |
| Interaction | EPHA4 interactions | 6.01e-05 | 188 | 143 | 8 | int:EPHA4 | |
| Interaction | ERBIN interactions | 1.18e-04 | 265 | 143 | 9 | int:ERBIN | |
| Interaction | CRYGC interactions | 1.20e-04 | 14 | 143 | 3 | int:CRYGC | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.77e-15 | 14 | 99 | 8 | 1095 | |
| GeneFamily | Fibronectin type III domain containing | EPHB2 EPHB3 EPHA6 DCC FNDC9 TNR EPHA3 EPHA4 EPHA5 EPHA7 EPHA8 | 1.19e-09 | 160 | 99 | 11 | 555 |
| GeneFamily | Sterile alpha motif domain containing | 1.22e-09 | 88 | 99 | 9 | 760 | |
| GeneFamily | Beta-gamma crystallins | 6.91e-05 | 15 | 99 | 3 | 1359 | |
| GeneFamily | Shisa family members | 8.13e-04 | 8 | 99 | 2 | 742 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 1.04e-03 | 9 | 99 | 2 | 1203 | |
| GeneFamily | ATP binding cassette subfamily A | 2.59e-03 | 14 | 99 | 2 | 805 | |
| GeneFamily | Dyneins, axonemal | 3.83e-03 | 17 | 99 | 2 | 536 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 9.33e-07 | 135 | 146 | 8 | M5825 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE GALNTL6 CACNA1F ABCA4 FRMPD4 DCC SCN9A DISP3 EPHA5 EPHA7 DNAH11 | 3.11e-11 | 184 | 148 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE GALNTL6 CACNA1F ABCA4 FRMPD4 DCC SCN9A DISP3 EPHA5 EPHA7 DNAH11 | 3.11e-11 | 184 | 148 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | TRHDE GALNTL6 CACNA1F ABCA4 FRMPD4 DCC SCN9A DISP3 EPHA5 EPHA7 DNAH11 | 3.11e-11 | 184 | 148 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-07 | 181 | 148 | 8 | 6e8c5460021d3999daec58e3d6661a6fa998fd16 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-06 | 158 | 148 | 7 | 91d265e95156f16459924d3e4dd11c180e164eee | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.06e-06 | 159 | 148 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.66e-06 | 170 | 148 | 7 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-06 | 178 | 148 | 7 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.25e-06 | 178 | 148 | 7 | f7f88879a05b2b5fa92cf5317b76f7a3064d1358 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.43e-06 | 180 | 148 | 7 | 2ae39e26a8e7d5d4d3e1e71609a8ec36fd9855aa | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-06 | 183 | 148 | 7 | b5d041d0a3506c33de72bf14fa0443f4410fddf1 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-06 | 183 | 148 | 7 | 274076a0978bce2bd53a1732045f18ef0f2d9985 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.23e-06 | 188 | 148 | 7 | 50c1b1d690f0e9443082f2adf4f1b8e9ce4cd337 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.35e-06 | 189 | 148 | 7 | f7d57723b8fb0f1e1485f51e3eff93ec0f39761e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 192 | 148 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 82caaee79e697ed4ddea7dd49e99b7abe849604f | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 0d559f7d8bfd24bcdc770fe2f3baebfddda9b640 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 32231471987dd5647c9f7c430ff62dc366b5aea8 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-ESR1---L3-5|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.86e-06 | 200 | 148 | 7 | 622ca21b7949ec3d40e17ea08ce4212bbfb963db | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.56e-06 | 133 | 148 | 6 | f303ab771482281d8793974f9f5279cee09431fe | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.13e-06 | 145 | 148 | 6 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 148 | 148 | 6 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Crispld2_Kcne4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.39e-05 | 156 | 148 | 6 | 896e2d958be0a5c62fb6eebad2dfb7e1ce69f3ad | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.44e-05 | 157 | 148 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 1.49e-05 | 158 | 148 | 6 | 7098847804dd90fa1dd74536e4e90f989b630fe4 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 160 | 148 | 6 | 9049707a4487f2337a17976ceb5fbd8815ab9e1d | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory-Ionocyte-Ionocyte|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 160 | 148 | 6 | f2cfec54cf48a655f473b830be7d141c54b521ff | |
| ToppCell | cellseq2-Epithelial-Epithelial_Neuro-Secretory|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.60e-05 | 160 | 148 | 6 | 0eb50b3c494e1b65d40104b3b5411b57bb72b959 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.72e-05 | 162 | 148 | 6 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 162 | 148 | 6 | 93bd29c52846c3156b8b0d2e39c552373efdfe93 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.78e-05 | 163 | 148 | 6 | 66ecd544d7b52e61880b125bf39d1f406af6900a | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 165 | 148 | 6 | 36415924d05373e9dd3665be599f4f3f40bf0497 | |
| ToppCell | facs-Heart-RA-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-05 | 165 | 148 | 6 | 56310fddd3d8e4afdfde066d26cee9747e5b8c6a | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.18e-05 | 169 | 148 | 6 | 41cb92b0558f0d5a3e511058efd9110258b88ee3 | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.18e-05 | 169 | 148 | 6 | 91f4b6a14708e701b2af22989004282041777491 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 2.41e-05 | 172 | 148 | 6 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-05 | 176 | 148 | 6 | 212e643c50c68462d4b016428ab30eeb7868ef40 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.74e-05 | 176 | 148 | 6 | 5d3b2395bb842eea39175f5af6a4c76527e2fc31 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-05 | 177 | 148 | 6 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_LINC01474|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.92e-05 | 178 | 148 | 6 | 5522b179c2e7dd707de01e2df10556349d0382a6 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 180 | 148 | 6 | b673d11d764e275883fc5edbad97137a6549df6a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.30e-05 | 182 | 148 | 6 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 183 | 148 | 6 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-05 | 183 | 148 | 6 | 92fbd83a9d13ee91065cbd479fb298f1fd564568 | |
| ToppCell | COVID-19-APC-like|COVID-19 / group, cell type (main and fine annotations) | 3.41e-05 | 183 | 148 | 6 | b8f5afaf9ff1b2b1bc60be58654d1b23859dafa9 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-05 | 185 | 148 | 6 | d4076294571557c223f5b68244e9c53e1d8f0343 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | a8fcb440d88770f95678c5d28413fc4d847f42a8 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.73e-05 | 186 | 148 | 6 | 9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | 6b2d15e2756d4d4d68ad600e4a6c074edc3488f2 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.73e-05 | 186 | 148 | 6 | 683f59985fbc5d3ba2412c788b4647dbbf42699a | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.84e-05 | 187 | 148 | 6 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-B_cell-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 188 | 148 | 6 | 9526d9e035eadbb0dcd4ad6e79a3a2b7f7845d74 | |
| ToppCell | droplet-Lung-3m-Hematologic-lymphocytic-B_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.96e-05 | 188 | 148 | 6 | 7c542b226240adcb7797be0ded6523e5732f0078 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 3.96e-05 | 188 | 148 | 6 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 3.96e-05 | 188 | 148 | 6 | b73e8a40393c3f656e2fcfe395a761b1f985c254 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.96e-05 | 188 | 148 | 6 | 9fc3819aae5a2b2534cb131d467435b5cfc420d6 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.96e-05 | 188 | 148 | 6 | 5e5d779ea079d3b2a1ef650b06b9f5cc1ffef5e7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.08e-05 | 189 | 148 | 6 | 3b35022c0619df6db234613aa53a076899ca9562 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.08e-05 | 189 | 148 | 6 | 358ff514f1c8aa46067208ddf1b68396d789c130 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-05 | 189 | 148 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.20e-05 | 190 | 148 | 6 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | BL-critical-LOC-Epithelial-Squamous|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.32e-05 | 191 | 148 | 6 | 3f9b8c4fb72ae6f3167b187e6715c4dcb3159f98 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | 30e7cc5f7eadf90ab0900a73fdfe48f9a1adcbfb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.32e-05 | 191 | 148 | 6 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-SMG_Basal/Duct-SMG_Basal/Duct|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 191 | 148 | 6 | 41d2f5278f6d5f52a5bdf4f3df70969481c00162 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.45e-05 | 192 | 148 | 6 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.58e-05 | 193 | 148 | 6 | 6b3a2a32ec6dc96230cee4bbf03932f8a81e6683 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.58e-05 | 193 | 148 | 6 | 0499611c21d283321ef6dd24add154dea48da1b7 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.58e-05 | 193 | 148 | 6 | b18c61e360f5f094f260007a56b189e2a48369e4 | |
| ToppCell | NS-critical-d_0-4-Epithelial-Squamous|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.72e-05 | 194 | 148 | 6 | 614d0c25b56957c70f397abb169fd2a860eb1c06 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.72e-05 | 194 | 148 | 6 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Developing_Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 4.85e-05 | 195 | 148 | 6 | de23409b1b4146b8ae286850b829ec8dceed0117 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-05 | 195 | 148 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 195 | 148 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.14e-05 | 197 | 148 | 6 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.28e-05 | 198 | 148 | 6 | df546a9afc0e15398f33c1b511c7281771f9aea0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.28e-05 | 198 | 148 | 6 | 399760b6b6fef8639ded53b14f251b9fce600e81 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.43e-05 | 199 | 148 | 6 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Neuronal-Excitatory-eC(RORB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.58e-05 | 200 | 148 | 6 | 8c803a0ce25e140b46036f6aabefc5502601f408 | |
| ToppCell | MS-IIF-Myeloid-cDC|IIF / Disease, condition lineage and cell class | 5.58e-05 | 200 | 148 | 6 | 620a82805619d113182d59740670c9f9b93ee924 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c10-IFNG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.38e-05 | 126 | 148 | 5 | d19382597ce5c6546731ac1fd33c7dcb7916b2ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.40e-05 | 130 | 148 | 5 | 7d4319aae42acc914757796877b8f0d874acbec4 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.82e-05 | 138 | 148 | 5 | 05de2cef97c0912fb23f138dd45348f565a14d74 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 143 | 148 | 5 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.16e-04 | 143 | 148 | 5 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.16e-04 | 143 | 148 | 5 | 5fb5a4ea93e5cce55d427e3b4a50a979504fad3c | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.20e-04 | 144 | 148 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.24e-04 | 145 | 148 | 5 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.26e-04 | 77 | 148 | 4 | a799ccdb84014e978d9fbccf3d2fee8fbeac7b0c | |
| ToppCell | Club-club-6|World / Class top | 1.26e-04 | 77 | 148 | 4 | 3653cf20b1b312578a54ffd33e75a8b92874f9bf | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.36e-04 | 148 | 148 | 5 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.41e-04 | 149 | 148 | 5 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | Club_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-04 | 149 | 148 | 5 | 81c813588bb5efb7b31141a75d387210dcb76094 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 151 | 148 | 5 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | Adult-Epithelial-basal_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.59e-04 | 153 | 148 | 5 | 9ee3e7f3f19a2474283c1c79045269686f35a541 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-04 | 153 | 148 | 5 | 499670e716fc85ce76630fc813cec86f8419f2a1 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 157 | 148 | 5 | 0673c7161c25feceee8f1e5fd237171576c42c6b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 157 | 148 | 5 | d307d0b48af35e0e1af41ecd3ebf91be8fd29dc0 | |
| Computational | Genes in the cancer module 80. | 4.95e-06 | 32 | 86 | 5 | MODULE_80 | |
| Computational | Genes in the cancer module 51. | 9.04e-06 | 36 | 86 | 5 | MODULE_51 | |
| Computational | Genes in the cancer module 85. | 5.13e-05 | 51 | 86 | 5 | MODULE_85 | |
| Computational | Genes in the cancer module 199. | 8.80e-05 | 57 | 86 | 5 | MODULE_199 | |
| Computational | RTK signaling. | 4.82e-04 | 46 | 86 | 4 | MODULE_259 | |
| Drug | ponatinib | 3.99e-10 | 68 | 142 | 9 | ctd:C545373 | |
| Drug | DFC-28 | 1.68e-08 | 14 | 142 | 5 | CID005743054 | |
| Drug | BIRB796 | 1.81e-07 | 66 | 142 | 7 | CID000156422 | |
| Drug | Reidispongiolide C | EPHB2 EPHB3 LAMA5 DCC SORT1 ADRA2A EFNA4 RNPEP EPHA3 EPHA4 EPHA5 EPHA8 | 1.92e-07 | 279 | 142 | 12 | CID005289285 |
| Drug | vandetanib | 1.99e-07 | 99 | 142 | 8 | CID003081361 | |
| Drug | NSC93767 | 1.55e-06 | 32 | 142 | 5 | CID000005658 | |
| Drug | sorafenib | 6.88e-06 | 158 | 142 | 8 | CID000216239 | |
| Drug | pentobarbital | 1.18e-05 | 224 | 142 | 9 | CID000004737 | |
| Drug | verapamil | CACNA1F CACNA2D1 ABCA1 ABCA4 HCN3 BIRC6 ADRA2A RNPEP SLC25A40 SCN4A SCN7A SCN9A MUSK | 1.27e-05 | 490 | 142 | 13 | CID000002520 |
| Drug | VX-745 | 1.66e-05 | 25 | 142 | 4 | CID003038525 | |
| Drug | EKB-569 | 1.77e-05 | 87 | 142 | 6 | CID006445562 | |
| Drug | AC1NSAUM | 2.84e-05 | 57 | 142 | 5 | CID005357474 | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; HL60; HG-U133A | 3.40e-05 | 197 | 142 | 8 | 1372_DN | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 1.36e-05 | 10 | 145 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 1.36e-05 | 10 | 145 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Large cell carcinoma of lung | 1.81e-05 | 32 | 145 | 4 | C0345958 | |
| Disease | brain infarction (biomarker_via_orthology) | 2.05e-05 | 33 | 145 | 4 | DOID:3454 (biomarker_via_orthology) | |
| Disease | cataract 2 multiple types (implicated_via_orthology) | 2.40e-05 | 2 | 145 | 2 | DOID:0110235 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 2.48e-05 | 12 | 145 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Nuclear non-senile cataract | 8.98e-05 | 18 | 145 | 3 | C1112705 | |
| Disease | Nuclear cataract | 8.98e-05 | 18 | 145 | 3 | C0392557 | |
| Disease | Congenital stationary night blindness | 1.43e-04 | 4 | 145 | 2 | cv:C0339535 | |
| Disease | CATARACT, AUTOSOMAL DOMINANT | 1.43e-04 | 4 | 145 | 2 | C1858679 | |
| Disease | congenital stationary night blindness (is_implicated_in) | 1.43e-04 | 4 | 145 | 2 | DOID:0050534 (is_implicated_in) | |
| Disease | level of Phosphatidylcholine (18:1_20:4) in blood serum | 1.45e-04 | 21 | 145 | 3 | OBA_2045104 | |
| Disease | Colorectal Carcinoma | ABCA1 ABCA4 GALNS RNPEPL1 RET DCC NDST3 FCN1 CHD5 VPS13A EPHA3 EPHA7 | 1.90e-04 | 702 | 145 | 12 | C0009402 |
| Disease | phosphatidylcholine acyl-alkyl C36:5 measurement | 2.38e-04 | 5 | 145 | 2 | EFO_0801293 | |
| Disease | procollagen C-endopeptidase enhancer 1 measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0801920 | |
| Disease | 1-(1-enyl-stearoyl)-2-arachidonoyl-GPC (P-18:0/20:4) measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0800394 | |
| Disease | stromelysin-2 measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0802095 | |
| Disease | 1-(1-enyl-palmitoyl)-GPC (P-16:0) measurement | 3.55e-04 | 6 | 145 | 2 | EFO_0800323 | |
| Disease | metabolite measurement | LIPF DCC CPT2 TMEM229B SLC7A9 OLFM3 RNPEP FUT6 NDUFV1-DT MUSK | 4.69e-04 | 560 | 145 | 10 | EFO_0004725 |
| Disease | serum IgA measurement | 4.72e-04 | 31 | 145 | 3 | EFO_0004912 | |
| Disease | level of Phosphatidylcholine (O-18:2_20:4) in blood serum | 4.96e-04 | 7 | 145 | 2 | OBA_2045135 | |
| Disease | peripheral neuropathy | 4.96e-04 | 7 | 145 | 2 | EFO_0003100 | |
| Disease | retinal degeneration (implicated_via_orthology) | 5.69e-04 | 33 | 145 | 3 | DOID:8466 (implicated_via_orthology) | |
| Disease | Spinocerebellar Ataxia Type 2 | 6.22e-04 | 34 | 145 | 3 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 6.22e-04 | 34 | 145 | 3 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 6.22e-04 | 34 | 145 | 3 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 6.22e-04 | 34 | 145 | 3 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 6.22e-04 | 34 | 145 | 3 | C0752124 | |
| Disease | Ataxia, Spinocerebellar | 6.22e-04 | 34 | 145 | 3 | C0087012 | |
| Disease | Disorder of eye | 6.51e-04 | 212 | 145 | 6 | C0015397 | |
| Disease | Ependymoma | 6.59e-04 | 8 | 145 | 2 | C0014474 | |
| Disease | Leigh syndrome | 6.59e-04 | 8 | 145 | 2 | cv:C0023264 | |
| Disease | level of Phosphatidylinositol (16:0_18:2) in blood serum | 6.59e-04 | 8 | 145 | 2 | OBA_2045153 | |
| Disease | 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPC (P-16:0/20:4) measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0800423 | |
| Disease | 1-(1-enyl-palmitoyl)-2-oleoyl-GPC (P-16:0/18:1) measurement | 6.59e-04 | 8 | 145 | 2 | EFO_0800420 | |
| Disease | Spinocerebellar Ataxia Type 4 | 6.78e-04 | 35 | 145 | 3 | C0752122 | |
| Disease | Burkitt Lymphoma | 7.37e-04 | 36 | 145 | 3 | C0006413 | |
| Disease | response to serotonin-norephinephrine reuptake inhibitor | 7.37e-04 | 36 | 145 | 3 | EFO_0006325 | |
| Disease | macrophage colony stimulating factor measurement | 7.99e-04 | 37 | 145 | 3 | EFO_0008217 | |
| Disease | Cataract | 7.99e-04 | 37 | 145 | 3 | C0086543 | |
| Disease | CATARACT, COPPOCK-LIKE | 8.44e-04 | 9 | 145 | 2 | C1852438 | |
| Disease | Cataract microcornea syndrome | 8.44e-04 | 9 | 145 | 2 | C1861829 | |
| Disease | Cataract, Pulverulent | 8.44e-04 | 9 | 145 | 2 | C1833118 | |
| Disease | lactate measurement | 9.33e-04 | 39 | 145 | 3 | EFO_0007745 | |
| Disease | complement C1q subcomponent subunit C measurement | 1.05e-03 | 10 | 145 | 2 | EFO_0801492 | |
| Disease | asthma exacerbation measurement | 1.16e-03 | 93 | 145 | 4 | EFO_0007614 | |
| Disease | level of Phosphatidylcholine (O-16:1_20:4) in blood serum | 1.28e-03 | 11 | 145 | 2 | OBA_2045123 | |
| Disease | Night blindness, congenital stationary, type 1 | 1.53e-03 | 12 | 145 | 2 | C3501847 | |
| Disease | Secondary Open Angle Glaucoma | 1.53e-03 | 12 | 145 | 2 | C0271148 | |
| Disease | Night Blindness, Congenital Stationary, Type 1A | 1.53e-03 | 12 | 145 | 2 | C3495587 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B (disorder) | 1.53e-03 | 12 | 145 | 2 | C1864877 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1B | 1.53e-03 | 12 | 145 | 2 | C1850362 | |
| Disease | X-Linked Csnb | 1.53e-03 | 12 | 145 | 2 | C3711543 | |
| Disease | 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement | 1.53e-03 | 12 | 145 | 2 | EFO_0800466 | |
| Disease | NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2A | 1.53e-03 | 12 | 145 | 2 | C1848172 | |
| Disease | Glaucoma, Open-Angle | 1.53e-03 | 12 | 145 | 2 | C0017612 | |
| Disease | total blood protein measurement | 1.76e-03 | 449 | 145 | 8 | EFO_0004536 | |
| Disease | Cone-rod synaptic disorder, congenital nonprogressive | 1.81e-03 | 13 | 145 | 2 | C4041558 | |
| Disease | Glaucoma, Primary Open Angle | 1.81e-03 | 13 | 145 | 2 | C0339573 | |
| Disease | phosphatidylcholine ether measurement | 1.81e-03 | 13 | 145 | 2 | EFO_0010227 | |
| Disease | Mitochondrial disease | 1.81e-03 | 49 | 145 | 3 | cv:C0751651 | |
| Disease | cognitive inhibition measurement | 1.92e-03 | 50 | 145 | 3 | EFO_0007969 | |
| Disease | Metastatic melanoma | 2.40e-03 | 54 | 145 | 3 | C0278883 | |
| Disease | African Burkitt's lymphoma | 2.41e-03 | 15 | 145 | 2 | C0343640 | |
| Disease | phosphatidylcholine 36:3 measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0010381 | |
| Disease | Burkitt Leukemia | 2.41e-03 | 15 | 145 | 2 | C4721444 | |
| Disease | tumor necrosis factor beta measurement | 2.41e-03 | 15 | 145 | 2 | EFO_0008308 | |
| Disease | HOMA-B | 2.53e-03 | 55 | 145 | 3 | EFO_0004469 | |
| Disease | antihyperlipidemic drug use measurement | 2.54e-03 | 115 | 145 | 4 | EFO_0803367 | |
| Disease | Neuralgia, Supraorbital | 2.75e-03 | 16 | 145 | 2 | C0038870 | |
| Disease | Neuralgia | 2.75e-03 | 16 | 145 | 2 | C0027796 | |
| Disease | Neuralgia, Atypical | 2.75e-03 | 16 | 145 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 2.75e-03 | 16 | 145 | 2 | C0234249 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 2.75e-03 | 16 | 145 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 2.75e-03 | 16 | 145 | 2 | C0423711 | |
| Disease | Paroxysmal Nerve Pain | 2.75e-03 | 16 | 145 | 2 | C0751373 | |
| Disease | Nerve Pain | 2.75e-03 | 16 | 145 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 2.75e-03 | 16 | 145 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 2.75e-03 | 16 | 145 | 2 | C0042656 | |
| Disease | esophageal carcinoma, gastric carcinoma | 3.11e-03 | 17 | 145 | 2 | EFO_0000178, EFO_0002916 | |
| Disease | Night blindness, congenital stationary | 3.11e-03 | 17 | 145 | 2 | C0339535 | |
| Disease | sweet liking measurement | 3.48e-03 | 18 | 145 | 2 | EFO_0010156 | |
| Disease | lysophosphatidylcholine 22:6 measurement | 3.48e-03 | 18 | 145 | 2 | EFO_0010365 | |
| Disease | hip bone mineral density | 3.52e-03 | 126 | 145 | 4 | EFO_0007702 | |
| Disease | Adenocarcinoma of lung (disorder) | 3.58e-03 | 206 | 145 | 5 | C0152013 | |
| Disease | esterified cholesterol measurement | 3.73e-03 | 128 | 145 | 4 | EFO_0008589 | |
| Disease | inferior parietal cortex volume measurement | 3.88e-03 | 19 | 145 | 2 | EFO_0010307 | |
| Disease | mosquito bite reaction size measurement | 4.04e-03 | 212 | 145 | 5 | EFO_0008378 | |
| Disease | acetate measurement | 4.30e-03 | 20 | 145 | 2 | EFO_0010112 | |
| Disease | fatty acid measurement, linoleic acid measurement | 4.61e-03 | 68 | 145 | 3 | EFO_0005110, EFO_0006807 | |
| Disease | BMI-adjusted waist-hip ratio, physical activity measurement | 4.81e-03 | 69 | 145 | 3 | EFO_0007788, EFO_0008002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YEGWLAGYQMNFETA | 146 | P21796 | |
| FVGTDYLYPGWNMEK | 471 | Q9UKU6 | |
| GSLELAMTHPEFYWY | 366 | Q9P2K9 | |
| AMTHPEFYWYVDEGL | 371 | Q9P2K9 | |
| SSMADPFKRRGYWYF | 1131 | Q7Z7A1 | |
| MLLYGDRVDSWTPFY | 101 | P78357 | |
| YIWMEYDQPLYVGSA | 906 | P78357 | |
| PMPAGAAAANYTYWA | 91 | O71037 | |
| HYMASDVEWDPTGRY | 651 | P55884 | |
| YLEYAKRAAPFNNWM | 511 | P12814 | |
| YVWGRYDLLFMPPSF | 281 | Q9H4A4 | |
| YRWAQPDPMAQAGFY | 301 | Q9NR09 | |
| REFEMWAPDFYVVTY | 766 | Q8TDI0 | |
| FRYIWGGFAYLQDMV | 601 | P78363 | |
| VVSYGERPYWEMTNQ | 871 | P54756 | |
| DPFEDMRYVWGGFAY | 581 | O95477 | |
| MRYVWGGFAYLQDVV | 586 | O95477 | |
| ELSNRSVYGMFPFWY | 606 | A8K2U0 | |
| YTDRPDWQSVMQYVA | 1046 | Q5M775 | |
| LDMMYREPARWSYTF | 96 | Q16854 | |
| PWEDLRYLFGEIMYG | 4131 | Q96DT5 | |
| SSMDWAYKNGIPYAF | 381 | Q8N4T0 | |
| YRNYDIPAEMTGLWR | 361 | Q9NZA1 | |
| MSWTDLFSNEEYYPA | 31 | Q9UKW6 | |
| SVDSNFQYGWTPLMY | 71 | Q8WWH4 | |
| FQYGWTPLMYAASVA | 76 | Q8WWH4 | |
| YWVMEGQLSNPTFYL | 1286 | O94823 | |
| YTGEMAWIYQPYGRN | 321 | O43307 | |
| YISGPWFDMYLSARD | 111 | P23786 | |
| WRYDNQRQFMEPGYP | 396 | P22894 | |
| NYHRGIDWYMDFFPV | 641 | O95803 | |
| EEAQTWCMENGDYPY | 136 | Q9NP90 | |
| WPIYNYQVFNGSREM | 341 | Q6ZNF0 | |
| VYTWPDGSMYEGEVV | 146 | P0C881 | |
| VYTWPDGSMYEGEVV | 146 | B2RC85 | |
| DAMGYELPWVYFVSL | 341 | O60840 | |
| YFDMWGGDVAPFIEF | 121 | Q92520 | |
| ENFWMIRGYAVLPDY | 346 | Q9H306 | |
| AMYTFRVVAYNEWGP | 496 | P43146 | |
| SMRVREWYGYHFPEL | 186 | O00567 | |
| FTFSDYYMSWIRQAP | 46 | P01762 | |
| LEVYEMWRNYPFLFG | 101 | Q9GZQ4 | |
| PLTAVYTIMDYWIFG | 96 | P50391 | |
| FFYRPMFEVIEDGWH | 111 | Q96QG7 | |
| FWAFSYDEMARFDLP | 151 | Q5VYY2 | |
| FGYQLPMVDSFKWYS | 511 | P59045 | |
| LMWEAFSYGQKPYRG | 561 | P43405 | |
| MYRPNWNSIFSGYLR | 31 | Q8TBE3 | |
| WDPNDMFRYNEENYG | 396 | Q99700 | |
| SDMYYGQSLLQPGEW | 1166 | Q2LD37 | |
| AAVVMYNFYRWFPSG | 121 | Q8IYD8 | |
| LSYMAPWFREEEVQY | 26 | O95786 | |
| EVMSYGERPYWDMSN | 816 | P54764 | |
| SYGERPYWDMTNQDV | 821 | P29323 | |
| YDWGSPVQNRMHYDQ | 306 | P07098 | |
| RMQYDWSDRNLDYPS | 236 | O60437 | |
| ETFALYMVDWPGYES | 71 | P52798 | |
| WYLDNVYPEMQISGS | 446 | Q8NCW6 | |
| VWYRTFMMEYPSGLQ | 21 | O95843 | |
| ETWVNLAMVDYPYAS | 281 | P42785 | |
| VMSYGERPYWDMSNQ | 831 | P54753 | |
| HYFIAAVERLWDYGM | 1716 | P00451 | |
| DDGYPWDMMYVTRFA | 226 | O60774 | |
| MDFGRTYQPWQFFAS | 176 | O15230 | |
| IHPYSDFRFYWDLIM | 86 | Q9P1Z3 | |
| SYGERPYWDMSNQDV | 831 | Q15375 | |
| YAFLPIWYVEAMTQD | 371 | O77932 | |
| PGFYAEWFQRFMCNT | 381 | A2A3N6 | |
| AAMAYDRYVAIWSPL | 116 | Q8NGG1 | |
| RMDGSVDFYRDWAAY | 161 | O00602 | |
| YRDWEMVGRYYEEFP | 181 | P34059 | |
| YFLRRGDYADHQQWM | 56 | P07320 | |
| LMPGDYRRYQDWGAT | 146 | P07320 | |
| YNSYSKRPDNENGWM | 236 | O95838 | |
| YTADEDGVWYSVAPM | 351 | Q53G59 | |
| LYDLGWYRPSGQMYS | 241 | A8MY62 | |
| RWNVDTGPDYYRDMD | 91 | Q68J44 | |
| VPWDDLRYLFGEIMY | 4076 | Q9UFH2 | |
| PMPAGAAAANYTYWA | 91 | P61570 | |
| PMPAGAAAANYTYWA | 91 | Q69384 | |
| WMACENKGYYYEIPS | 401 | P54289 | |
| YWTLDPDSYNMFENG | 151 | Q12948 | |
| PYGWEMTANRDGRDY | 36 | Q14CM0 | |
| YDNLFETSFPYSMGW | 286 | P07902 | |
| MEAYGPIPAYLFSWA | 101 | P82251 | |
| VLAYGERPYWNMTNR | 831 | P29322 | |
| AWVYAEPTMYGEILS | 11 | P09871 | |
| YGVSPNYDKWEMERT | 226 | P00519 | |
| AGAYYGMDQVPESWQ | 326 | Q9NX46 | |
| GEYPDYQQWMGLSDS | 61 | P07316 | |
| MSYRSDSDIFTPYGW | 156 | P51993 | |
| EVMSYGERPYWEMSN | 816 | P29320 | |
| MPAGAAAANYTNWAY | 91 | P61565 | |
| WAVDPFGYSSTMPYL | 286 | P49641 | |
| GEYPDYQQWMGLSDS | 61 | P07315 | |
| ISWRSDYEDPAFYML | 136 | Q9HBE5 | |
| MAAGTLYTYPENWRA | 1 | P26641 | |
| PMPAGAAAANYTYWA | 91 | Q902F9 | |
| DRNDYRSMYPVWKSF | 76 | O94868 | |
| FRDGYMPRQYSLQNW | 266 | P48637 | |
| EFYADYSDNPWLMGV | 871 | P51530 | |
| PGGQWIYMSDNYTDV | 961 | O75923 | |
| WLREPAFYQVGILYM | 271 | Q6NUT3 | |
| DPFMTTDNGNYFWDR | 521 | Q16820 | |
| VYPYTWGGFSDIDLM | 336 | Q96PB7 | |
| MTLYWGADYEVPQSQ | 106 | Q12923 | |
| SYGERPYWEMSNQDV | 871 | Q9UF33 | |
| YYYRDDGMQIWGAVE | 471 | O15296 | |
| IDPIAMEYYNWGRFS | 111 | Q9GZY6 | |
| TWMDEFAEYIYQRRP | 391 | Q49A17 | |
| YMVYPQTFALNADRW | 91 | Q9NP92 | |
| MPDSYSPRYVEAAWY | 296 | P26640 | |
| AWLENMPYNIYIGEA | 226 | Q8IW52 | |
| EQWLSAAERLYGPYM | 296 | Q9HAU8 | |
| AAERLYGPYMWGRYD | 301 | Q9HAU8 | |
| MVPDVYISDDGGYSW | 501 | Q99523 | |
| AMDPYEYFQQGWNIF | 631 | P35499 | |
| AESATLPAWMRLYFY | 46 | B2RXF0 | |
| CPWDYSQFDFDFMGL | 101 | Q8NBD8 | |
| PTVLRDVPFSAMYWY | 201 | Q8TBP6 | |
| LYPEERYMDNNSRLW | 71 | P56278 | |
| WPDAQFQLGFMYYSG | 406 | Q5TEA6 | |
| NLPGYFWYKGEMTDL | 61 | Q00887 | |
| WANMFSYDNYEGSAP | 521 | Q14697 | |
| VRWYQMGAYQPFFRA | 661 | Q14697 | |
| TRIAYYAMGFDWRIG | 86 | P32249 | |
| AFDPRSAYYLWFVMD | 106 | Q8N165 | |
| IAMDPYEYFQVGWNI | 796 | Q15858 | |
| RGYYDVMGQWDPPFN | 61 | B8ZZ34 | |
| PDFCRGYFDVMGQWD | 71 | B4DS77 | |
| FMWRFARAYGDMYEL | 216 | Q96LZ7 | |
| MTGQLVDLPEYYSWG | 801 | Q15477 | |
| IAQWRKAGYQDMPEY | 666 | Q15437 | |
| VIPFSLANEVMGYWY | 101 | P08913 | |
| MEQWDYYKSQTRFAP | 146 | Q8NBR9 | |
| KFYDYEANMPDRWGH | 96 | Q6ZUT1 | |
| PVPAMIASSDYYFSW | 281 | Q12884 | |
| FQEEMAPLWYQRSYI | 276 | A0A0J9YY54 | |
| DKYFPDNWVISIYMG | 281 | Q12768 | |
| EVHYYNEMFGVWEPL | 1771 | Q96RL7 | |
| LSVYSEDGWDLPYIM | 2091 | Q96RL7 | |
| RDIVFEPYWMIYGEV | 1011 | Q9BX84 | |
| MQPASAKWYDRRDYV | 1 | Q15185 | |
| LAREMGYFSQYVAWV | 731 | Q8N271 | |
| GFMYIRYTQPPTDLW | 161 | Q5VTL8 | |
| FPFMYWSYGRQQGLS | 196 | Q8TBR7 | |
| WYRQYSGKSPELIMF | 56 | A0A075B6T6 | |
| WDGPMAVTEYVISYQ | 346 | Q92752 | |
| MVSWSPPVASFDYYR | 881 | Q92752 | |
| DLQHIWPFMYGDYIA | 191 | Q9C0C9 | |
| PLTAVYTIMDYWIFG | 96 | P0DQD5 | |
| WYMMDEGYDEFHNPL | 326 | Q92620 | |
| WASYRNMGDLFGPFY | 1711 | Q9UGU0 | |
| WALYYDRREPGTDQM | 246 | O95859 | |
| GFPRYPNDSVYANWM | 1086 | P07949 | |
| PYWMIYGEVFADQID | 1006 | Q7Z4N2 | |
| PYGYFQVGWNIFDSM | 561 | Q01118 | |
| IDYTAYPWFAGNMER | 666 | P52735 | |
| DIGRQDWPMFYHDFF | 116 | Q96QU8 | |
| QRYPKDSTAWMEQFY | 2741 | Q6ZQQ6 | |
| VPMERVFDYSEYWEG | 826 | P11498 | |
| AYAPQGWIAFFMEYV | 536 | Q8TEY7 | |
| YQPRWRGEYLMDYDG | 581 | C9JLR9 | |
| FIGDWMRCLYGEAYP | 726 | O76024 | |
| ESPELYDWLYLGFMA | 51 | Q9P055 | |
| IRWMPPESIFYNRYT | 766 | O15146 |